These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16724057)

  • 1. Validating cancer drug targets.
    Benson JD; Chen YN; Cornell-Kennon SA; Dorsch M; Kim S; Leszczyniecka M; Sellers WR; Lengauer C
    Nature; 2006 May; 441(7092):451-6. PubMed ID: 16724057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing preclinical mouse models to inform human clinical cancer trials.
    Gutmann DH; Hunter-Schaedle K; Shannon KM
    J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug target validation: Hitting the target.
    Smith C
    Nature; 2003 Mar; 422(6929):341, 343, 345 passim. PubMed ID: 12646927
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying and validating novel targets with in vivo disease models: guidelines for study design.
    Anders HJ; Vielhauer V
    Drug Discov Today; 2007 Jun; 12(11-12):446-51. PubMed ID: 17532528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNAs in drug discovery: target validation and beyond.
    Natt F
    Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional proteomic screens in therapeutic protein drug discovery.
    Ilag LL
    Curr Opin Mol Ther; 2005 Dec; 7(6):538-42. PubMed ID: 16370376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfinished business: target-based drug discovery.
    Brown D
    Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.
    Schreiber K; Rowley DA; Riethmüller G; Schreiber H
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):567-84. PubMed ID: 16762725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinases in drug discovery and development.
    Hadari YR
    IDrugs; 2001 Dec; 4(12):1329-32. PubMed ID: 15931557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening the receptorome: an efficient approach for drug discovery and target validation.
    Strachan RT; Ferrara G; Roth BL
    Drug Discov Today; 2006 Aug; 11(15-16):708-16. PubMed ID: 16846798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of treatment results with biological agents: is there a need for a new methodology?
    Begent RH
    J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preclinical data as basis for the design of clinical studies].
    Fichtner I
    Onkologie; 2008; 31 Suppl 2():34-8. PubMed ID: 18487867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tools for drug discovery: tools of the trade.
    Smith C
    Nature; 2007 Mar; 446(7132):219-22. PubMed ID: 17344855
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies to optimize the validity of disease models in the drug discovery process.
    Sams-Dodd F
    Drug Discov Today; 2006 Apr; 11(7-8):355-63. PubMed ID: 16580978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fishing for new antimicrobials.
    Mukhopadhyay A; Peterson RT
    Curr Opin Chem Biol; 2006 Aug; 10(4):327-33. PubMed ID: 16822704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into drug development for pediatric solid tumors: what preclinical data justify clinical trials in pediatric cancer?
    Houghton PJ
    Expert Rev Anticancer Ther; 2013 Oct; 13(10):1135-8. PubMed ID: 24093514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.